Domestic pharmaceutical business emerging from slump

Published: 2004-02-09 07:00:00

Updated: 2004-02-09 07:00:00

Local brokerages believe that the domestic pharmaceutical business conditions have begun to pick up after the fourth quarter of 2003, buoyed by positive signs of drug shipment index and drug retailer sales index.

According to a report released by Kim Hee-sung, an analyst from Hanyang Securitie...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK